STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
Novartis
Neonc Technologies, Inc.
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
St. Jude Children's Research Hospital
NRG Oncology
Mayo Clinic
Yale University
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Milton S. Hershey Medical Center
AC Camargo Cancer Center
Centre Leon Berard
University of California, San Francisco
Chinese PLA General Hospital
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NRG Oncology
Stanford University
University Hospital, Antwerp
Dana-Farber Cancer Institute
NGM Biopharmaceuticals, Inc
University of Southern California
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
University of Florida
M.D. Anderson Cancer Center
Sumitomo Pharma America, Inc.
SCRI Development Innovations, LLC
Eastern Cooperative Oncology Group
Duke University
Five Prime Therapeutics, Inc.
Gilead Sciences
Emory University
Celgene
Emory University
Cambridge University Hospitals NHS Foundation Trust
Shenzhen BinDeBio Ltd.
Celldex Therapeutics
Stanford University
Yale University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Merck Sharp & Dohme LLC
Masonic Cancer Center, University of Minnesota
University of Southern California
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Institut Claudius Regaud
Children's Oncology Group
National Cancer Institute (NCI)